The Avantor Korea Laboratory will help biopharmaceutical and pharmaceutical customers improve the efficiency of their purification processes, with an initial focus on helping them optimise Avantor’s high-performance resins, buffers and other materials used in their production systems.
This specialised lab features state-of-the-art life sciences research tools, expert scientists, application specialists and resources, and accommodations to provide on-site training for topics such as biopharmaceutical drug development, process validation and regulatory compliance.
Devashish Ohri, Executive VP of APAC and MEA for Avantor, said: “We created the new Avantor Korea Laboratory to enable more collaboration with our customers in Korea’s fast-growing life sciences industry. Our goal is to help optimise process efficiency and yields, solve drug development bottlenecks and create integrated solutions to address customer business objectives.”
Process development and optimisation is one area in which the Avantor Korea Laboratory researchers will work closely with customers.
Avantor researchers will collaborate on ways to use the company’s process chromatography media, buffers and salts to define the best conditions for the highest protein purity and protein yield.
Nandu Deorkar, VP of Research and Development for Avantor, said: “With more than 30 years of experience in process chromatography, we have developed multi-mode chemistry that works to increase yield by improving purification process efficiency and also enhancing selectivity by removing closely related impurities. We will apply that experience to the challenges our Korean life sciences customers hope to solve.”
The Avantor Korea Laboratory also provides process optimisation expertise through its newly launched Field Application Services (FAS) programmes.
FAS programmes cover R&D/Pre-Clinical stage process development as well as Phase I/II/III/Marketed stage processes.
These expert, step-by-step services are designed to help improve protein yield and target protein purity, reduce process time and/or steps, and potentially reduce the time from research and development to commercialisation of target products.
This new research facility is part of Avantor’s expanding footprint of research and application development laboratories located around the world, including the Bridgewater Innovation Center, the company’s newest North American research lab supporting the development of chemistries and materials for life sciences and advanced technologies customers.